Implementing HIV Testing in Substance Use Treatment Programs: A Systematic Review

Claire A. Simeone, Stella M. Seal, Christine L. Savage

Research output: Contribution to journalArticle

Abstract

People who use drugs are at increased risk for HIV acquisition, poor engagement in health care, and late screening for HIV with advanced HIV at diagnosis and increased HIV-related morbidity, mortality, and health care costs. This systematic review evaluates current evidence about the effectiveness and feasibility of implementing HIV testing in U.S. substance use treatment programs. The literature search identified 535 articles. Full text review was limited to articles that explicitly addressed strategies to implement HIV testing in substance use programs: 17 met criteria and were included in the review; nine used quantitative, qualitative, or mixed-method designs to describe or quantify HIV testing rates, acceptance by clients and staff, and cost-effectiveness; eight organization surveys described barriers and facilitators to testing implementation. The evidence supported the effectiveness and feasibility of rapid, routine, and streamlined HIV testing in substance use treatment programs. Primary challenges included organizational support and sustainable funding.

Original languageEnglish (US)
JournalJournal of the Association of Nurses in AIDS Care
DOIs
StateAccepted/In press - 2016
Externally publishedYes

Fingerprint

HIV
Health Care Costs
Cost-Benefit Analysis
Organizations
Morbidity
Delivery of Health Care
Mortality
Pharmaceutical Preparations

Keywords

  • HIV
  • Implementation
  • Program
  • Rapid testing
  • Substance use

ASJC Scopus subject areas

  • Advanced and Specialized Nursing

Cite this

@article{cc99a704e7544c0095da42d5dc10693b,
title = "Implementing HIV Testing in Substance Use Treatment Programs: A Systematic Review",
abstract = "People who use drugs are at increased risk for HIV acquisition, poor engagement in health care, and late screening for HIV with advanced HIV at diagnosis and increased HIV-related morbidity, mortality, and health care costs. This systematic review evaluates current evidence about the effectiveness and feasibility of implementing HIV testing in U.S. substance use treatment programs. The literature search identified 535 articles. Full text review was limited to articles that explicitly addressed strategies to implement HIV testing in substance use programs: 17 met criteria and were included in the review; nine used quantitative, qualitative, or mixed-method designs to describe or quantify HIV testing rates, acceptance by clients and staff, and cost-effectiveness; eight organization surveys described barriers and facilitators to testing implementation. The evidence supported the effectiveness and feasibility of rapid, routine, and streamlined HIV testing in substance use treatment programs. Primary challenges included organizational support and sustainable funding.",
keywords = "HIV, Implementation, Program, Rapid testing, Substance use",
author = "Simeone, {Claire A.} and Seal, {Stella M.} and Savage, {Christine L.}",
year = "2016",
doi = "10.1016/j.jana.2015.11.006",
language = "English (US)",
journal = "Journal of the Association of Nurses in AIDS Care",
issn = "1055-3290",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Implementing HIV Testing in Substance Use Treatment Programs

T2 - A Systematic Review

AU - Simeone, Claire A.

AU - Seal, Stella M.

AU - Savage, Christine L.

PY - 2016

Y1 - 2016

N2 - People who use drugs are at increased risk for HIV acquisition, poor engagement in health care, and late screening for HIV with advanced HIV at diagnosis and increased HIV-related morbidity, mortality, and health care costs. This systematic review evaluates current evidence about the effectiveness and feasibility of implementing HIV testing in U.S. substance use treatment programs. The literature search identified 535 articles. Full text review was limited to articles that explicitly addressed strategies to implement HIV testing in substance use programs: 17 met criteria and were included in the review; nine used quantitative, qualitative, or mixed-method designs to describe or quantify HIV testing rates, acceptance by clients and staff, and cost-effectiveness; eight organization surveys described barriers and facilitators to testing implementation. The evidence supported the effectiveness and feasibility of rapid, routine, and streamlined HIV testing in substance use treatment programs. Primary challenges included organizational support and sustainable funding.

AB - People who use drugs are at increased risk for HIV acquisition, poor engagement in health care, and late screening for HIV with advanced HIV at diagnosis and increased HIV-related morbidity, mortality, and health care costs. This systematic review evaluates current evidence about the effectiveness and feasibility of implementing HIV testing in U.S. substance use treatment programs. The literature search identified 535 articles. Full text review was limited to articles that explicitly addressed strategies to implement HIV testing in substance use programs: 17 met criteria and were included in the review; nine used quantitative, qualitative, or mixed-method designs to describe or quantify HIV testing rates, acceptance by clients and staff, and cost-effectiveness; eight organization surveys described barriers and facilitators to testing implementation. The evidence supported the effectiveness and feasibility of rapid, routine, and streamlined HIV testing in substance use treatment programs. Primary challenges included organizational support and sustainable funding.

KW - HIV

KW - Implementation

KW - Program

KW - Rapid testing

KW - Substance use

UR - http://www.scopus.com/inward/record.url?scp=84955587051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955587051&partnerID=8YFLogxK

U2 - 10.1016/j.jana.2015.11.006

DO - 10.1016/j.jana.2015.11.006

M3 - Article

C2 - 26825458

AN - SCOPUS:84955587051

JO - Journal of the Association of Nurses in AIDS Care

JF - Journal of the Association of Nurses in AIDS Care

SN - 1055-3290

ER -